HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,344 | +5.3% | 113,720 | -0.5% | 0.01% | +11.1% |
| Q2 2023 | $4,124 | -6.7% | 114,320 | -1.2% | 0.01% | -10.0% |
| Q1 2023 | $4,418 | -33.6% | 115,681 | -1.1% | 0.01% | -37.5% |
| Q4 2022 | $6,652 | -99.9% | 116,914 | +0.2% | 0.02% | +33.3% |
| Q3 2022 | $4,616,000 | -10.6% | 116,736 | -0.5% | 0.01% | -7.7% |
| Q2 2022 | $5,162,000 | +14.1% | 117,323 | +3.4% | 0.01% | +44.4% |
| Q1 2022 | $4,526,000 | -0.6% | 113,486 | +0.2% | 0.01% | 0.0% |
| Q4 2021 | $4,555,000 | +15.8% | 113,286 | +17.1% | 0.01% | +12.5% |
| Q3 2021 | $3,935,000 | -0.6% | 96,728 | +10.9% | 0.01% | 0.0% |
| Q2 2021 | $3,960,000 | +13.7% | 87,211 | +4.4% | 0.01% | +14.3% |
| Q1 2021 | $3,483,000 | +2237.6% | 83,553 | +2287.2% | 0.01% | – |
| Q4 2020 | $149,000 | – | 3,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,816,162 | $191,226,000 | 8.73% |
| BB BIOTECH AG | 6,825,532 | $65,866,000 | 2.13% |
| Lombard Odier Asset Management (USA) Corp | 2,700,000 | $26,055,000 | 1.79% |
| SECTORAL ASSET MANAGEMENT INC | 3,724,351 | $35,940,000 | 1.61% |
| QVT Financial LP | 2,010,186 | $19,398,000 | 0.97% |
| JHL Capital Group LLC | 1,475,000 | $14,234,000 | 0.94% |
| MAZAMA CAPITAL MANAGEMENT INC | 358,087 | $3,456,000 | 0.79% |
| EcoR1 Capital, LLC | 160,700 | $1,551,000 | 0.78% |
| Alden Global Capital Ltd | 332,500 | $3,209,000 | 0.77% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 7,274,065 | $70,195,000 | 0.65% |